Purple Biotech (PPBT) Interest Income - Debt Securities (2024 - 2026)
Purple Biotech (PPBT) posted quarterly Interest Income - Debt Securities of -$2.2 million for Q1 2026, down 133.4% year-over-year from $6.5 million in Q1 2025, and down 2836.49% quarter-over-quarter from -$74000.0 in Q2 2025.
Purple Biotech (PPBT) Interest Income - Debt Securities (2024 - 2026) Analysis & Trends
Purple Biotech (PPBT) has reported Interest Income - Debt Securities for 3 consecutive years, with -$2.2 million the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Debt Securities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Purple Biotech | 130.35 | 130.35 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.17 Mn |
| Jun 30, 2025 | -74,000.00 |
| Mar 31, 2025 | -931,000.00 |
| Jun 30, 2024 | -946,000.00 |
| Mar 31, 2024 | -607,000.00 |